Performance of VRTX Vertex Pharmaceuticals | 16.3% in 12m
Compare VRTX with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Vertex Pharmaceuticals with its related Sector/Index XBI
Performance Duell VRTX vs XBI
| TimeFrame | VRTX | XBI |
|---|---|---|
| 1 Day | -0.32% | 2.43% |
| 1 Week | -0.93% | 2.11% |
| 1 Month | -5.22% | -9.87% |
| 3 Months | -9.09% | -5.81% |
| 6 Months | 10.8% | 31.21% |
| 12 Months | 16.3% | 6.65% |
| YTD | -3.58% | -5.22% |
| Rel. Perf. 1m | 0.62 | |
| Rel. Perf. 3m | 0.11 | |
| Rel. Perf. 6m | -1.54 | |
| Rel. Perf. 12m | 1.11 |
Is Vertex Pharmaceuticals a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Vertex Pharmaceuticals (NASDAQ:VRTX) is currently (April 2024)
a good stock to buy. It has a ValueRay Fundamental Rating of 61.84 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of VRTX as of April 2024 is 376.13. This means that VRTX is currently overvalued and has a potential downside of -5.07% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of VRTX as of April 2024 is 376.13. This means that VRTX is currently overvalued and has a potential downside of -5.07% (Sold with Premium).
Is VRTX a buy, sell or hold?
- Strong Buy: 14
- Buy: 6
- Hold: 10
- Sell: 1
- Strong Sell: 2
Values above 0%: VRTX is performing better - Values below 0%: VRTX is underperforming
Compare VRTX with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -3.00% | -2.73% | -12.77% | -8.13% |
| US NASDAQ 100 | QQQ | -4.26% | -2.68% | -13.56% | -18.78% |
| US Dow Jones Industrial 30 | DIA | -1.30% | -1.76% | -6.83% | 1.56% |
| German DAX 40 | DBXD | -2.35% | -3.13% | -12.03% | 3.13% |
| UK FTSE 100 | ISFU | -4.28% | -7.10% | -6.11% | 8.94% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -4.07% | -8.79% | 8.77% | 28.72% |
| Hongkong Hang Seng | HSI | -9.27% | -9.66% | 12.60% | 35.06% |
| Japan Nikkei 225 | EXX7 | -1.24% | 2.43% | -7.51% | -2.01% |
| India NIFTY 50 | INDA | -2.16% | -7.04% | -10.39% | -11.71% |
| Brasil Bovespa | EWZ | -3.32% | -3.15% | -0.53% | -2.89% |
VRTX Vertex Pharmaceuticals vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -0.43% | -2.18% | -12.76% | -17.14% |
| Consumer Discretionary | XLY | -6.50% | -3.10% | -8.87% | -6.40% |
| Consumer Staples | XLP | -1.83% | -4.53% | -2.98% | 15.49% |
| Energy | XLE | -1.77% | -7.32% | -4.70% | -0.86% |
| Financial | XLF | -0.66% | -1.99% | -17.60% | -8.79% |
| Health Care | XLV | -1.61% | -0.28% | -3.48% | 9.39% |
| Industrial | XLI | -2.66% | -3.25% | -16.71% | -9.27% |
| Materials | XLB | -2.30% | -2.40% | -9.64% | 1.91% |
| Real Estate | XLRE | -2.87% | 1.51% | -4.77% | 15.13% |
| Technology | XLK | -4.25% | -1.58% | -12.87% | -17.86% |
| Utilities | XLU | -2.54% | -7.41% | -4.54% | 15.67% |
| Aerospace & Defense | XAR | -4.29% | -2.96% | -11.01% | -4.36% |
| Biotech | XBI | -3.04% | 4.65% | -20.37% | 9.63% |
| Homebuilder | XHB | -4.45% | 1.15% | -37.39% | -32.27% |
| Retail | XRT | -3.35% | 2.11% | -15.66% | -4.60% |
Does Vertex Pharmaceuticals outperform its market, is VRTX a Sector Leader?
Yes, over the last 12 months Vertex Pharmaceuticals (VRTX) made 16.28%, while its related Sector, the SPDR S&P Biotech (XBI) made 6.65%.
Over the last 3 months VRTX made -9.09%, while XBI made -5.81%.
Yes, over the last 12 months Vertex Pharmaceuticals (VRTX) made 16.28%, while its related Sector, the SPDR S&P Biotech (XBI) made 6.65%.
Over the last 3 months VRTX made -9.09%, while XBI made -5.81%.
| Period | VRTX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -5.22% | -9.87% | -2.49% |
| 3 Months | -9.09% | -5.81% | 4.15% |
| 12 Months | 16.28% | 6.65% | 24.41% |